Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...

Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Veeva Systems (NYSE:VEEV) saw a 6% price increase last week, potentially influenced by the announcement of Tina Hunt's upcoming retirement from the board. This governance change may have reassured ...

Veeva Systems aims to provide immediate value for commercial operations and data analytics teams via CRM Pulse, which provides quarterly HCP access data.

We came across a bullish thesis on Veeva Systems Inc. (VEEV) on Substack by Francesco Ferrari. In this article, we will ...

Stephens reissued their overweight rating on shares of Veeva Systems (NYSE:VEEV – Free Report) in a research note released on ...

Needham & Company LLC restated their buy rating on shares of Veeva Systems (NYSE:VEEV – Free Report) in a report released on ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid fourth-quarter fiscal 2025 performance and strategic ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...

Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, ...

I foresee continued margin expansion and revenue growth recovery to 16% by FY27 for VEEV, supported by CRM migration and easing capital funding challenges. Veeva released Q4 result on March 5 th ...